lobbying_activities: 2874184

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2874184	aa7a3040-d1fc-4546-9781-fca18e87161d	3A	CAMPAIGN FOR TOBACCO-FREE KIDS	27401	CAMPAIGN FOR TOBACCO-FREE KIDS	2022	third_quarter	TOB	Lobbying Report: July 1 - September 30, 2022 Legislation: H.R. 8239 House FY 2023 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Lobbying activities related to FY 2023 appropriations for the Food and Drug Administration and regulation of tobacco products) H.R. 8294 FY 2023 Consolidated Appropriations Act (Lobbying activities related to FY 2023 appropriations for the Food and Drug Administration and regulation of tobacco products) H.R. 8295 House FY 2023 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies (Lobbying activities related to FY 2023 appropriations for the Centers for Disease Control and Prevention) Senate FY 2023 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Lobbying activities related to FY 2022 appropriations for the Food and Drug Administration and regulation of tobacco products) H.R. 5376 Inflation Reduction Act of 2022 Senate FY 2023 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies (Lobbying activities related to FY 2023 appropriations for the Centers for Disease Control and Prevention) H.R. 2125 Quit Because of COVID-19 Act H.R. 8202 Preventing Vape Use Act Issues FDA action to address synthetic nicotine FDA premarket review of e-cigarettes FDAs proposed rules on menthol cigarettes and flavored cigars Medicaid and tobacco cessation Reducing nicotine levels in cigarettes Tobacco cessation in general Tobaccos role in health disparities Agencies Visited: Centers for Disease Control and Prevention US House of Representatives US Senate Food and Drug Administration	Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE		113000	0	0	2022-10-19T09:51:06-04:00